This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Howard University, The University of Texas System. Active years: 2012-2016.
Company Filing History:
2 out of 97 
1 out of 5,633 
Years Active: 2012-2016
Title: The Innovations of Sergei Nekhai
Introduction
Sergei Nekhai is a notable inventor based in McLean, VA (US), recognized for his contributions to the field of biomedical research. With a focus on viral infections, he has developed innovative solutions that aim to combat serious health threats.
Latest Patents
Nekhahi holds 2 patents that highlight his groundbreaking work. His latest patents include "Inhibitors of Protein Phosphatase-1 and Uses Thereof," which disclose inhibitors of protein phosphatase-1 (PP-1) and their application in treating or preventing viral infections caused by HIV or the Ebola virus. These inhibitors have demonstrated the ability to slow down viral replication when in contact with the Ebola virus or cells infected with it. Additionally, his work on inhibitors of protein phosphatase-1 has shown effectiveness in slowing the replication of HIV-1, providing a potential avenue for treatment or prevention of HIV-1 infections.
Career Highlights
Throughout his career, Nekhai has been associated with prestigious institutions such as Howard University and the University of Texas System. His work has significantly contributed to the understanding and treatment of viral infections, showcasing his dedication to advancing medical science.
Collaborations
Nekhahi has collaborated with esteemed colleagues, including Dmytro Borysovich Kovalskyy and Alexander Bukreyev, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Sergei Nekhai's innovative work in developing inhibitors for viral infections positions him as a key figure in biomedical research. His contributions not only advance scientific knowledge but also hold promise for future therapeutic applications.